VT News
Gulomjon Abdullaev

Gulomjon Abdullaev

Ask VT AI
View News Summary
  • FDA rejects Capricor's cell therapy for Duchenne cardiomyopathy, citing insufficient evidence, but the company plans to resubmit with new trial data.
  • Trump imposes 35% tariff on Canadian imports, citing trade disputes and fentanyl trafficking as national security threats.
  • Pro-Palestinian activist Mahmoud Khalil files $20M claim against Trump administration for false imprisonment, malicious prosecution, and defamation.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • FDA rejects Capricor's cell therapy for Duchenne cardiomyopathy, citing insufficient evidence, but the company plans to resubmit with new trial data.
  • Trump imposes 35% tariff on Canadian imports, citing trade disputes and fentanyl trafficking as national security threats.
  • Pro-Palestinian activist Mahmoud Khalil files $20M claim against Trump administration for false imprisonment, malicious prosecution, and defamation.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Gulomjon Abdullaev

Top Topics

Trending in U.S.

World

Sport